Olaparib Efficacy In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Carrying Circulating Tumor (Ct) Dna Alterations In Brca1, Brca2 Or Atm: Results From The Profound Study.

Nobuaki Matsubara, Johann S. De Bono,David Olmos,Giuseppe Procopio,Satoru Kawakami,Yuksel Urun,Robbert J. van Alphen, Aude Flechon,Michael Anthony Carducci,Young Deuk Choi,Sebastien J. Hotte,Ernesto Pablo Korbenfeld,Gero Kramer,Neeraj Agarwal,Simon Dearden,Christopher Gresty,Jinyu Kang,Christian Heinrich Poehlein,Elizabeth Harrington,Maha H. A. Hussain

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 16|浏览17

暂无评分

摘要

27Background: ctDNA testing offers additional opportunities for homologous recombination repair (HRR) gene alteration determination in patients who are not able to access tumor tissue testing. Alte...

查看译文

关键词

olaparib efficacy,prostate cancer,mcrpc,castration-resistant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要